Article Text

PDF
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)
  1. L Silveira-Moriyama1,
  2. P Schwingenschuh2,6,
  3. A O’Donnell3,
  4. S A Schneider2,
  5. P Mir4,
  6. F Carrillo4,
  7. C Terranova2,
  8. A Petrie5,
  9. D G Grosset3,
  10. N P Quinn2,
  11. K P Bhatia2,
  12. A J Lees1
  1. 1
    Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK
  2. 2
    Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK
  3. 3
    Institute of Neurological Sciences, Department of Neurology, Southern General Hospital, Glasgow, UK
  4. 4
    Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, CIBERNED, Seville, Spain
  5. 5
    Biostatistics Unit, UCL Eastman Dental Institute, London, UK
  6. 6
    Department of Neurology, Medical University Graz, Austria
  1. Professor A Lees, Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1 Wakefield St, London WC1N 1PJ, UK; alees{at}ion.ucl.ac.uk

Abstract

Background: Positron emission tomography and single photon emission computed tomography scanning have 87–94% sensitivity and 80–100% specificity to differentiate patients with Parkinson’s disease (PD) from control subjects and patients with essential (ET) or atypical tremor. More than 10% of patients diagnosed as early PD can have scans without evidence of dopaminergic deficiency (SWEDDs). This study investigated whether smell tests can help identify possible cases with SWEDDs.

Methods: The 40 item University of Pennsylvania Smell Test (UPSIT) was used to evaluate the sense of smell in 21 SWEDDs patients. Twenty-six ET patients, 16 patients with a diagnosis of idiopathic adult onset dystonia (D), 191 non-demented PD patients and 136 control subjects were also tested. Multiple regression analyses were used to compare the mean UPSIT score in the SWEDDs group with the other four groups (ET, D, PD and controls) after adjusting for the effects of relevant covariates.

Results: The mean UPSIT score for the SWEDDs group was greater than in the PD group (p<0.001) and not different from the mean UPSIT in the control (p = 0.7), ET (p = 0.4) or D (p = 0.9) groups. Smell tests indicated a high probability of PD in only 23.8% of SWEDDs as opposed to 85.3% of PD patients.

Conclusions: In a patient with suspected PD, a high PD probability on smell testing favours the diagnosis of PD, and a low PD probability strengthens the indication for dopamine transporter imaging.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Funding: This work was funded by the Reta Lila Weston Trust for Medical Research and LS-M is a beneficiary of a Reta Lila Weston fellowship. PS was funded by the Austrian Science Fund (FWF, Erwin Schrödinger Grant).

  • Ethics approval: Ethics Committee approval was obtained from the regional and local ethics committee in the National Hospital for Neurology and Neurosurgery, London, UK and regional and local ethics committee in the Southern General Hospital, Glasgow, UK.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.